Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial
<p>Abstract</p> <p>Background</p> <p>It has been estimated that between 5% and 10% of women diagnosed with breast cancer have a hereditary form of the disease, primarily caused by a <it>BRCA1 </it>or <it>BRCA2 </it>gene mutation. Such women have...
Main Authors: | Valdimarsdottir Heiddis B, van der Luijt Rob B, Hogervorst Frans BL, Hahn Daniela EE, Bleiker Eveline MA, Verhoef Senno, Ausems Margreet GEM, Wevers Marijke R, van Hillegersberg Richard, Rutgers Emiel, Aaronson Neil K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/6 |
Similar Items
-
Withdrawal from Genetic Counselling for Cancer
by: Bleiker Eveline, et al.
Published: (2005-02-01) -
Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
by: Mary E. Velthuizen, et al.
Published: (2021-01-01) -
The contribution of <it>CHEK2 </it>to the <it>TP53</it>-negative Li-Fraumeni phenotype
by: Ruijs Marielle WG, et al.
Published: (2009-02-01) -
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
by: Saadatmand Sepideh, et al.
Published: (2012-10-01) -
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; <it>BRCA1 </it>and <it>BRCA2 </it>as an example
by: Gómez García Encarna, et al.
Published: (2009-06-01)